These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26162513)

  • 1. Elution of High Dose Amphotericin B Deoxycholate From Polymethylmethacrylate.
    Houdek MT; Greenwood-Quaintance KE; Morrey ME; Patel R; Hanssen AD
    J Arthroplasty; 2015 Dec; 30(12):2308-10. PubMed ID: 26162513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of different amphotericin B formulations from PMMA bone cements and their activity against Candida biofilm.
    Czuban M; Wulsten D; Wang L; Di Luca M; Trampuz A
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110406. PubMed ID: 31401462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement.
    Silverberg D; Kodali P; Dipersio J; Acus R; Askew M
    Clin Orthop Relat Res; 2002 Oct; (403):228-31. PubMed ID: 12360031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal formulation increases local delivery of amphotericin from bone cement: a pilot study.
    Cunningham B; McLaren AC; Pauken C; McLemore R
    Clin Orthop Relat Res; 2012 Oct; 470(10):2671-6. PubMed ID: 22467417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elution and mechanical properties of antifungal bone cement.
    Goss B; Lutton C; Weinrauch P; Jabur M; Gillett G; Crawford R
    J Arthroplasty; 2007 Sep; 22(6):902-8. PubMed ID: 17826283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment.
    Falci DR; dos Santos RP; Wirth F; Goldani LZ
    Mycoses; 2011 Mar; 54(2):91-8. PubMed ID: 19878457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. British HIV Association opportunistic infection guidelines: in defence of amphotericin B deoxycholate.
    Bicanic T; Ogden D; Whitney L; Loyse A; Jarvis J
    HIV Med; 2012 Nov; 13(10):636-7. PubMed ID: 23051823
    [No Abstract]   [Full Text] [Related]  

  • 8. Amphotericin B delivery from bone cement increases with porosity but strength decreases.
    Kweon C; McLaren AC; Leon C; McLemore R
    Clin Orthop Relat Res; 2011 Nov; 469(11):3002-7. PubMed ID: 21638100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index.
    Zia Q; Azhar A; Kamal MA; Aliev G; Owais M; Ashraf GM
    Curr Pharm Des; 2016; 22(7):792-803. PubMed ID: 26648472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion of amphotericin B deoxycholate: a cost-effective gold standard for therapy of invasive fungal infections?
    Schneemann M; Bachli EB
    Clin Infect Dis; 2004 Jan; 38(2):303-4; author reply 306-7. PubMed ID: 14699468
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences in tissue drug concentrations following intravenous versus intraperitoneal treatment with amphotericin B deoxycholate or liposomal amphotericin B.
    Chang T; Olson JA; Proffitt RT; Adler-Moore JP
    Med Mycol; 2010 Mar; 48(2):430-5. PubMed ID: 20141377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New methods for delivery of antifungal agents.
    Meunier F
    Rev Infect Dis; 1989; 11 Suppl 7():S1605-12. PubMed ID: 2690298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B lipid complex.
    Rapp RP; Gubbins PO; Evans ME
    Ann Pharmacother; 1997 Oct; 31(10):1174-86. PubMed ID: 9337444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is 24 hours infusion of amphotericin B deoxycholate as good as liposomal amphotericin B?
    Flückiger U
    Swiss Med Wkly; 2002 Aug; 132(31-32):431-2. PubMed ID: 12457300
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia.
    Rothenbühler C; Held U; Manz MG; Schanz U; Gerber B
    Hematol Oncol; 2018 Apr; 36(2):471-480. PubMed ID: 29431860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion of amphotericin B deoxycholate: does decreased nephrotoxicity couple with time-dependent pharmacodynamics?
    de Rosa FG; Bargiacchi O; Audagnotto S; Garazzino S; Ranieri VM; di Perri G
    Leuk Lymphoma; 2006 Sep; 47(9):1964-6. PubMed ID: 17065014
    [No Abstract]   [Full Text] [Related]  

  • 17. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate.
    Collette N; van der Auwera P; Lopez AP; Heymans C; Meunier F
    Antimicrob Agents Chemother; 1989 Mar; 33(3):362-8. PubMed ID: 2658785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Elution and Mechanical Properties of High-Dose Antibiotic-Loaded Bone Cement: Comparative "In Vitro" Study of the Influence of Vancomycin and Cefazolin.
    Paz E; Sanz-Ruiz P; Abenojar J; Vaquero-Martín J; Forriol F; Del Real JC
    J Arthroplasty; 2015 Aug; 30(8):1423-9. PubMed ID: 25791672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxycholate amphotericin B and nephrotoxicity in the pediatric setting.
    Bes DF; Rosanova MT; Sberna N; Arrizurieta E
    Pediatr Infect Dis J; 2014 Aug; 33(8):e198-206. PubMed ID: 24618932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.